Lanean...
Overview of CDK9 as a target in cancer research
CDK9 is a protein in constant development in cancer therapy. Herein we present an overview of the enzyme as a target for cancer therapy. We provide data on its characteristics and mechanism of action. In recent years, CDK9 inhibitors that have been designed with molecular modeling have demonstrated...
Gorde:
Argitaratua izan da: | Cell Cycle |
---|---|
Egile Nagusiak: | , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Taylor & Francis
2016
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056610/ https://ncbi.nlm.nih.gov/pubmed/26766294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1138186 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|